Evaluation of Alpha-Fetoprotein in Breast Cancer Patients in Nnewi North, Anambra State, Nigeria

Authors

Collins Uchechukwu Obi

Department of Clinical Chemistry, Faculty of Medical Laboratory Science, College of Medicine, Nnamdi Azikiwe University, Nnewi Campus, Anambra State (Nigeria)

Blessing Ben-Anioke

Department of Clinical Chemistry, Faculty of Medical Laboratory Science, College of Medicine, Nnamdi Azikiwe University, Nnewi Campus, Anambra State (Nigeria)

Ijeoma Nnenna Agbiogwu

Department of Clinical Chemistry, Faculty of Medical Laboratory Science, College of Medicine, Nnamdi Azikiwe University, Nnewi Campus, Anambra State (Nigeria)

Ogochukwu Chinwe Ugwunna

Department of Clinical Chemistry, Faculty of Medical Laboratory Science, College of Medicine, Nnamdi Azikiwe University, Nnewi Campus, Anambra State (Nigeria)

Chinwe Ejike

Department of Clinical Chemistry, Faculty of Medical Laboratory Science, College of Medicine, Nnamdi Azikiwe University, Nnewi Campus, Anambra State (Nigeria)

Ifeoma Joy Onuora

Department of Clinical Chemistry, Faculty of Medical Laboratory Science, College of Medicine, Nnamdi Azikiwe University, Nnewi Campus, Anambra State (Nigeria)

Ikechukwu Vincent Obi

Department of Clinical Chemistry, Faculty of Medical Laboratory Science, College of Medicine, Nnamdi Azikiwe University, Nnewi Campus, Anambra State (Nigeria)

Ikemba Blessing Amarachukwu

Department of Clinical Chemistry, Faculty of Medical Laboratory Science, College of Medicine, Nnamdi Azikiwe University, Nnewi Campus, Anambra State (Nigeria)

Article Information

DOI: 10.51244/IJRSI.2026.1315PH00045

Subject Category: Education

Volume/Issue: 13/15 | Page No: 1779-1791

Publication Timeline

Submitted: 2026-03-03

Accepted: 2026-03-18

Published: 2026-03-31

Abstract

Breast cancer remains the most frequently diagnosed malignancy and a leading cause of cancer-related mortality among women worldwide. It represents a major global public health concern due to its rising incidence, disease burden, and associated mortality. Breast cancer is not a single disease entity but rather a group of physiologically and molecularly heterogeneous disorders characterized by uncontrolled proliferation of breast epithelial cells. Although considerable progress has been made in early detection and therapeutic interventions, advanced breast cancer with distant metastasis remains largely incurable with currently available treatment modalities. In recent years, research efforts have focused on the identification of reliable biomarkers that can facilitate early diagnosis, improve prognostic evaluation, and enhance monitoring of treatment response. Alpha-fetoprotein (AFP), a glycoprotein typically produced during fetal development, has been proposed as a potential tumor biomarker in several malignancies. However, available literature describing the relationship between AFP levels and breast cancer progression remains limited and inconclusive. Furthermore, there is a notable lack of data examining AFP as a biomarker among breast cancer patients in Nigeria, particularly within Anambra State and Nnewi North. This knowledge gap highlights the need for localized research to determine the clinical relevance of AFP in breast cancer management among Nigerian populations. Objectives: The primary objective of this study was to evaluate serum alpha-fetoprotein levels in patients diagnosed with breast cancer. The specific objectives were to:
Determine and compare serum AFP levels between breast cancer patients and apparently healthy female control subjects. Assess the relationship between AFP levels and selected anthropometric parameters among breast cancer patients. Evaluate age-related variations in serum AFP levels among breast cancer patients and control individuals. Establish possible correlations between AFP levels and breast cancer occurrence and progression.

Keywords

Breast cancer, Alpha-fetoprotein (AFP), Tumor biomarker, Serum analysis, Nigeria

Downloads

References

1. Ali Salman, R. (2023). 'Prevalence of women breast cancer', Cellular, Molecular and Biomedical Reports, 3(4), pp. 185-196. doi: 10.55705/cmbr.2023.384467.1095 [Google Scholar] [Crossref]

2. Cancer Research UK (2023) ‘TNM staging for breast cancer’, Cancer Research UK. https://www.cancerresearchuk.org/about-cancer/breast-cancer/stages-grades/tnm-staging.(Accessed: 15 March 2025). [Google Scholar] [Crossref]

3. Chhikara, B. S.; Parang, K. Global Cancer Statistics 2022: The Trends Projection Analysis. Chem Biol Lett 2023, 10 (1), 451. [Google Scholar] [Crossref]

4. Cleveland Clinic (2024) 'Breast Anatomy: Milk Ducts, Tissue, Conditions and Physiology'. Available at: https://my.clevelandclinic.org/health/articles/8330-breast-anatomy (Accessed: 4 February 2025). [Google Scholar] [Crossref]

5. Creswell, J. W., and Creswell, J. D. (2018). Research design: Qualitative, quantitative, and mixed methods approach (5th ed.). [Google Scholar] [Crossref]

6. Głowska-Ciemny J., Szymański M, Kuszerska, A., Malewski Z, von Kaisenberg C, Kocyłowski R. The Role of Alpha-Fetoprotein (AFP) in Contemporary Oncology: The Path from a Diagnostic Biomarker to an Anticancer Drug. International Journal of Molecular Sciences. 2023; 24(3):2539. https://doi.org/10.3390/ijms24032539 [Google Scholar] [Crossref]

7. Jernström, H. and Barrett‐Connor, E. (2009). Obesity, Weight Change, Fasting Insulin, Proinsulin, C-Peptide, and Insulin-like Growth Factor-1 Levels in Women with and without Breast Cancer: The Rancho Bernardo Study. Journal of women’s health and gender-based medicine, 8(10), pp.1265–1272. doi:https://doi.org/10.1089/jwh.1.1999.8.1265. [Google Scholar] [Crossref]

8. Rebecca L.S., Kimberly D.M., Nikita S.W. and Ahmedin J.D., (2023). Cancer Statistics . DOI:10.3322/caac.21763 [Google Scholar] [Crossref]

9. Secher, N.J., Eriksen, P.S., Hansen, P.K., Lenstrup, C. and Thisted, J. (2019). High maternal serum alpha-fetoprotein and low birthweight. A study concerning possible correlation between maternal weight, smoking, and serum alpha-fetoprotein and subsequent birthweight and gestational age. American journal of perinatology, [online] 2(2), pp.78–81. doi:https://doi.org/10.1055/s-2007-999919. [Google Scholar] [Crossref]

10. Varzaru, V.B., Eftenoiu, A.-E., Vlad, D.C., Vlad, C.S., Moatar, A.E., Popescu, R. and Cobec, I.M. (2024). The Influence of Tumor-Specific Markers in Breast Cancer on Other Blood Parameters. Life, [online] 14(4), p.458. doi:https://doi.org/10.3390/life14040458. [Google Scholar] [Crossref]

11. Sakamoto, S., Putalun, W., Vimolmangkang, S., Phoolcharoen, W., Shoyama, Y., Tanaka, H., & Morimoto, S. (2018). Enzyme-linked immunosorbent assay for the quantitative/qualitative analysis of plant secondary metabolites. Journal of Natural Medicines, 72(1), 32–42. https://doi.org/10.1007/s11418-017-1144-z [Google Scholar] [Crossref]

12. Xu, P. (2014). Association between serum alpha-fetoprotein levels and fatty liver disease: A cross-sectional study. World Journal of Gastroenterology, 20(33), p.11865. doi:https://doi.org/10.3748/wjg.v20.i33.11865. [Google Scholar] [Crossref]

Metrics

Views & Downloads

Similar Articles